期刊文献+

应用NCCLS EP10-A2对自建生化检测系统进行初步性能评价 被引量:4

Preliminary Functional Evaluation of A Home-made Biochemical Detection System According to NCCLS EP10-A2
原文传递
导出
摘要 目的对自建生化检测系统进行初步性能评价。方法依照NCCLS制定的EP10-A2文件,使用自建体系测定血清肌酸激酶(CK)、总胆固醇(Tch)、尿素(Urea)、无机磷(Pi)等四个项目,计算其偏差、总不精密度,及其截距、斜率、非线性、互染率、漂移性,并进行t检验。结果CK、Tch低值、中值、高值偏差及总不精密度均在允许范围内;Urea、Pi低值偏差超过允许偏倚,中值、高值偏差及总不精密度均在允许范围内。CK截距、斜率、非线性、互染率、漂移性均无显著性差异。Tch、Pi截距有显著性差异,Urea斜率有显著性差异;Tch、Urea、Pi非线性、互染率、漂移性均无显著性差异。结论使用自建生化检测体系测定CK、Tch、Urea、Pi,总不精密度均小于1/3 CLIA’88 TEa,互染率较低,稳定性较好;但Urea、Pi低值与标准检测体系存在一定的差距,准确度有待改善。 Objective To evaluate the performance of a home-made biochemical testing system. Method The system consists of an OLYMPUS AU 400 biochemical analyzer, Roche c.f.a.s calibrator as well as its non-kit reagents. The testing was performed according to EP10-A2 protocol made by NCCLS to determine the indexes of CK, Tch, Urea and Pi. Their deviations, total imprecision, intercepts, slope rates, nonlinearities, carryover and drifts were calculated. T-test was used for data analysis. Result For measurement of CK, the deviation of low-, mid-, and high-value of Tch were all within the permissive ranges. There were no significant difference between their intercepts, slope rates, nonlinearities, carryover, and drifts. For the Urea, the low value deviation was beyond of permissive range while the mid and high values as well as total imprecision were in the permissive ranges. There were significant difference between the slope rates and no significant difference between their intercepts, nonlinearities, carryover, and drifts. For Pi, the low value deviation was beyond of permissive range while mid and high values as well as total imprecision were in the permissive ranges. There were significant difference between their intercepts and no significant difference between their slope rates, nonlinearities, carryover, and drifts. Conclusion The total imprecision were all less than 1/3 CLIA' 88 TEa, with lower carryover and better stability. Further improvement, especially the urea measurement and low Pi value, is required.
出处 《热带医学杂志》 CAS 2009年第8期951-953,共3页 Journal of Tropical Medicine
基金 广州番禺区科技局基金(No.2007-Z-74-1)
关键词 EP10-A2 自建检测系统 初步评价 EP10-A2 self-built testing system preliminary evaluation
  • 相关文献

参考文献3

二级参考文献8

  • 1李萍,刘小娟,徐克和,黄志刚.利用Westgard标准决定图判定测定方法性能[J].临床检验杂志,2006,24(1):69-70. 被引量:27
  • 2张秀明,庄俊华,徐宁,黄宪章,陈茶,尹一兵,梁伟雄.不同检测系统血清酶测定结果的偏倚评估与可比性研究[J].中华检验医学杂志,2006,29(4):346-349. 被引量:137
  • 3Westgard JO.A method evaluation decision chart (MEDx Chart)for judging method performance.Clin Lab Sci,1995,8:277-283.
  • 4Ricos C,Alvarez V,Cava F,et al.Current databases on biological variation:pros,cons and progress.Scand J Clin Lab Invest,1999,59:491-500.
  • 5Westgard JO,Burnett RW.Precision requirements for costeffective operation of analytical processes.Clin Chem,1990,36:1629-1632.
  • 6NCCLS.Preliminary Evaluation of Quantitative Clinical Laboratory Methods,Approved Guideline EP10-A.1998.1-2.
  • 7卫生部临床检验中心.临床实验室室间质评的要求(草案).2000年全国临床化学室间质评资料汇编.2000.1-23.
  • 8滕万钟,梁爱玲,肖春梅,樊瑞军,邱艳荣.应用NCCLS EP10-T_2评价国产电解质分析仪[J].宁夏医学杂志,1999,21(10):601-604. 被引量:5

共引文献75

同被引文献32

  • 1张秀明,庄俊华,徐宁,黄宪章,陈茶,尹一兵,梁伟雄.不同检测系统血清酶测定结果的偏倚评估与可比性研究[J].中华检验医学杂志,2006,29(4):346-349. 被引量:137
  • 2张秀明,李炜煊,蓝锴,郑松柏,陈滨鸿,孙蕾,林莲英,梁伟雄.自建生化检测系统的量值溯源性和可比性研究[J].检验医学,2007,22(3):299-303. 被引量:12
  • 3高月亭,陈涛,刘汉欣,刘忠民,李宁,肖洪广.应用EP10-A初步评价XI-921型电解质分析仪[J].现代临床医学生物工程学杂志,2006,12(6):507-509. 被引量:4
  • 4郑万华.全自动生化分析仪的发展及市场概况[J].上海生物医学工程,2007,28(2):124-125. 被引量:9
  • 5杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 6National Committee for Clinical Laboratory Standards.Method comparision and bias estimation using patient samples[S].2nd ed,EP9-A2,NCCLS,2002.
  • 7NCCLS. Preliminary evaluation of quantitative clinical laboratory methods IS]. Approved Guideline EP10-A2. 2002.
  • 8U.S. Department of Health and Human Services, Centers for Medicare&Medicaid Services. Clinical laboratory imp rovement amendments of 1988: final rule [S]. Fed Register, 2003.
  • 9NCCLS. Evaluation of the linearity of quantitative analytical methods IS]. Approved Guideline EP6-A2. 2003.
  • 10National Committee for Clinical Laboratory Standards.Medthod Comparison and Bias Estimation Using Patients Samples;Approved Guideline,EP09-A2[S].Ann Arbor:Thomson Reuters,2002.

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部